Labor Market Pulse · Life Sciences · September 2026
Life Sciences Labor Market Report: Rapid City, SD MSA — September 2026
Rapid City's scientific talent pool is tightening as pay signals diverge.
Biostatistician advertised pay fell sharply in the metro while national pay rose to $133,322, even as Rapid City unemployment held near 2.0% and statewide employers shed 900 private-sector jobs in August.
Free archive edition. Published by WageScape as sent to subscribers; data as of September 2026.
Key indicators
- Rapid City MSA unemployment: 2.0% — July 2026, among tightest metro markets nationally
- SD labor force participation: 66.5% — Down 1.7 pts YoY, 7th highest nationally
- SD private-sector jobs, August: -900 — Statewide net loss despite low unemployment
- Biostatistician advertised pay, metro vs US: $74,360 vs $133,322 — Metro down significantly, national up moderately
Key takeaways
Biostatistician pay is decoupling from the national market.
Metro median advertised pay for Biostatistician roles fell significantly even as national pay rose moderately to $133,322. Local employers risk losing quantitative talent to remote-eligible national postings if pay strategy doesn't account for this gap.
Clinical Research Associate demand is heating up locally and nationally.
Advertised CRA pay rose moderately in the metro and significantly nationally, consistent with sustained clinical-stage hiring pressure. Expect continued upward pressure on offers for this role through year-end.
Statewide job losses mask a tight specialized-talent market.
South Dakota shed 900 private-sector jobs in August even as unemployment held at 2.0%, suggesting broad hiring caution rather than loosening of the credentialed talent pool. Life Sci roles requiring regulatory, quality, or scientific credentials remain insulated from this softening.
Novartis postings signal a local pharma compensation anchor is forming.
Principal Scientist and VP Quality Assurance listings ($109K–$310K range) establish a visible in-state reference point for senior scientific and quality pay. Expect these postings to shape candidate expectations for comparable roles across the metro.
Median advertised pay by role — Rapid City, SD MSA
| Role | 25th percentile | Median advertised pay | 75th percentile | Metro trend | National median |
|---|---|---|---|---|---|
| Research Scientist * | $109,700 | $135,141 | $135,141 | Significant increase | $131,354 |
| Clinical Research Associate * | $60,320 | $73,060 | $85,510 | Moderate increase | $90,956 |
| Lab Technician * | $38,403 | $47,108 | $50,671 | Significant increase | $47,402 |
| Regulatory Affairs Specialist * | $75,529 | $81,143 | $89,023 | Moderate decline | $104,000 |
| Clinical Data Manager * | $99,344 | $111,806 | $114,422 | Significant decline | $123,031 |
| Biostatistician * | $58,356 | $74,360 | $108,363 | Significant decline | $133,322 |
| Validation Engineer | — | — | — | No data | $108,377 |
* State-level figure shown where metro postings were too few.
WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON
Local market conditions
Rapid City MSA unemployment held near 2.0% through mid-2026, with civilian labor force participation and employer demand outpacing available credentialed workers across healthcare and technical occupations. Statewide, falling labor force participation (down 1.7 points year-over-year to 66.5%) and a net loss of 900 private-sector jobs in August point to a labor market that is tight on supply but cautious on employer expansion, a combination that sharpens competition for the scientific and regulatory talent Life Sci employers need most.
What it means
Metro-level scarcity in technical and healthcare occupations, paired with statewide hiring caution, means Life Sci leaders are competing for a shrinking pool of qualified candidates while facing internal pressure to justify every new requisition. Advertised pay for Biostatistician roles fell sharply in the metro even as national pay for the same role climbed, a divergence that complicates local benchmarking and increases the risk of losing candidates to remote national postings; Clinical Research Associate pay rose on both fronts, signaling where local competition is intensifying fastest. Organizations should evaluate whether local postings for quantitative and clinical roles are priced against the right comparison set — national remote-eligible pay, not historical metro medians — before finalizing offers this quarter.
Looking ahead
Expected: BLS releases September state unemployment data October 20 and metro-level data typically follows with a lag; watch for confirmation of whether the August private-sector job loss was a one-month blip or the start of a trend.
Emerging pressure point: Falling statewide labor force participation (down 1.7 points year-over-year) suggests the available candidate pool for specialized clinical and regulatory roles may keep shrinking, independent of overall job counts.
Worth watching: National biopharma layoffs (BioMarin, Bristol Myers) are concentrated in consolidation functions rather than execution-critical science and quality roles; watch whether any displaced regulatory or CMC talent surfaces in regional or remote candidate searches reachable from Rapid City.
Potential inflection point: Discovery District's 2,800-worker life sciences build-out remains a 25-year horizon, offering no near-term headcount relief, but early site-selection or hiring announcements over the next 60 days would be the first concrete signal of accelerated timing.
Methodology
Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.
Free to read and cite with attribution to WageScape. Terms of use.